NFTs are a new an untested market. How do we evaluate “risk” on something with no track record?
Apr 8, 2021
Current strategy thoughts for Bitcoin. Longform version of this piece also to be used as a lead magnet.
23 & Me
Dec 31, 2021
23andMe is a genomics and biotechnology company that allows users to discover ancestry by submitting a cheek swab for genetic testing. They’ve announced that they’re planning to go public via a SPAC, sometime before June 2021.
This could be an ideal RISK Rituals. It gives us a news hook for looking at SPACs in general, and also touches on some of the privacy issues that we want to explore.